Breaking News Instant updates and real-time market news.

2022-07-07 06:38:03 FSR Fisker $8.78 / -0.155 (-1.74%) , SAN Banco Santander $2.61 / -0.09 (-3.34%) … 06:38 07/07/22 07/07 06:38 07/07/22 06:38	Fisker announces Fisker Finance platform Fisker announced Fisker Finance, a digital financing platform offering seamless and convenient loan purchase options to Fisker customers. The company also reaffirmed the nomination of Chase in the US and Santander Consumer Finance in Europe as retail financing partners, as noted in its February 2022 earnings release, with more announcements to come. Starting with buyers of the all-electric, five-passenger Fisker Ocean One, the Fisker Finance direct-to-consumer digital platform will enable customers to apply for vehicle financing, receiving competitive, personalized decisions, plus the ability to finance vehicle accessories such as home charging equipment and factory-installed accessories. Production of the Fisker Ocean is on track starting November 2022 at a carbon-neutral factory in Austria. Customers will be able to navigate the digital loan process at their own pace. Starting with the credit application on fiskerinc.com or Fisker's app, applicants can select a retail financing structure that best fits their needs. Customers will be able to review their financing details and electronically sign documents online. Following vehicle delivery, Fisker owners can digitally access their account, make payments and obtain personalized customer support. On July 1, Fisker began offering early reservation holders in select markets the opportunity to secure a Fisker Ocean One by committing to a $5,000 USD deposit. Fisker Finance plans to begin offering financing in the fourth quarter of 2022. Fisker expects to nominate financing partners in additional regions, with more announcements to come. FSR Fisker $8.78 / -0.155 (-1.74%) SAN Banco Santander $2.61 / -0.09 (-3.34%) JPM JPMorgan $111.89 / -0.78 (-0.69%)	14 Jul

2022-07-07 06:38:03

FSR

Fisker

$8.78 / -0.155 (-1.74%)

, SAN

Banco Santander

$2.61 / -0.09 (-3.34%)

… 06:38

07/07/22

07/07

06:38

07/07/22

06:38

Fisker announces Fisker Finance platform

Fisker announced Fisker Finance, a digital financing platform offering seamless and convenient loan purchase options to Fisker customers. The company also reaffirmed the nomination of Chase in the US and Santander Consumer Finance in Europe as retail financing partners, as noted in its February 2022 earnings release, with more announcements to come. Starting with buyers of the all-electric, five-passenger Fisker Ocean One, the Fisker Finance direct-to-consumer digital platform will enable customers to apply for vehicle financing, receiving competitive, personalized decisions, plus the ability to finance vehicle accessories such as home charging equipment and factory-installed accessories. Production of the Fisker Ocean is on track starting November 2022 at a carbon-neutral factory in Austria. Customers will be able to navigate the digital loan process at their own pace. Starting with the credit application on fiskerinc.com or Fisker's app, applicants can select a retail financing structure that best fits their needs. Customers will be able to review their financing details and electronically sign documents online. Following vehicle delivery, Fisker owners can digitally access their account, make payments and obtain personalized customer support. On July 1, Fisker began offering early reservation holders in select markets the opportunity to secure a Fisker Ocean One by committing to a $5,000 USD deposit. Fisker Finance plans to begin offering financing in the fourth quarter of 2022. Fisker expects to nominate financing partners in additional regions, with more announcements to come.

FSR

Fisker

$8.78 / -0.155 (-1.74%)

SAN

Banco Santander

$2.61 / -0.09 (-3.34%)

JPM

JPMorgan

$111.89 / -0.78 (-0.69%)

14
Jul

OTHER BREAKING NEWS FROM THE FLY

Upgrade	Tellurian upgraded to Buy at BofA on natural gas tailwinds » 06:34 08/09/22 08/09 06:34 08/09/22 06:34 TELL Tellurian $3.41 / +0.03 (+0.89%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TELL Tellurian $3.41 / +0.03 (+0.89%) 06/29/22 Baker Hughes awarded ICL contract by Tellurian subsidiary 05/16/22 Paulson exits Cerner, boosts Didi in Q1 05/16/22 Tellurian COO Keith Teague to retire 02/14/22 Paulson buys Cerner, exits Pretium in Q4 TELL Tellurian $3.41 / +0.03 (+0.89%) 06:08 Today BofA Tellurian upgraded to Buy from Neutral at BofA 08/01/22 Evercore ISI Tellurian downgraded to In Line from Outperform at Evercore ISI 08/01/22 Evercore ISI Tellurian downgraded to In Line from Outperform at Evercore ISI 06/06/22 Credit Suisse Tellurian price target lowered to $7 from $8 at Credit Suisse TELL Tellurian $3.41 / +0.03 (+0.89%) 08/03/22 Tellurian reports Q2 EPS 0c, consensus (2c) 05/04/22 Tellurian reports Q1 EPS (14c), consensus (2c) 02/23/22 Tellurian ended FY21 with approximately $305.5M in cash TELL Tellurian $3.41 / +0.03 (+0.89%) 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed On Wall Street This Morning 04/01/22 What You Missed On Wall Street On Friday 04/01/22 What You Missed On Wall Street This Morning TELL Tellurian $3.41 / +0.03 (+0.89%) 06/01/22 Unusually active option classes on open June 1st 05/20/22 Unusually active option classes on open May 20th 04/14/22 Tellurian call volume above normal and directionally bullish 03/25/22 Tellurian call volume above normal and directionally bullish
Recommendations	Zai Lab price target raised to $199 from $193 at Citi » 06:33 08/09/22 08/09 06:33 08/09/22 06:33 ZLAB Zai Lab $47.14 / +1.75 (+3.86%) , KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) Citi analyst Yigal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ZLAB KRTX ZLAB Zai Lab $47.14 / +1.75 (+3.86%) 08/08/22 Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial 07/13/22 Zai Lab announces acceptance by China's NMPA for the BLA for efgartigimod 06/10/22 Zai Lab announces breakthrough therapy designation for repotrectinib in China 06/03/22 Novocure, Zai Lab announce EF-31 phase 2 pilot study met primary endpoint KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial 08/08/22 Karuna Therapeutics says Phase 3 EMERGENT-2 trial met primary endpoint ZLAB KRTX ZLAB Zai Lab $47.14 / +1.75 (+3.86%) 05/12/22 Citi Zai Lab price target lowered to $193 from $198 at Citi 03/17/22 Citi Citi opens '90-day positive Catalyst Watch' on Zai Lab 02/23/22 Roth Capital Repotrectinib 'adds another feather' in China, says Roth Capital 12/15/21 JPMorgan Zai Lab weakness on 1155 bill 'overdone,' says JPMorgan KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 06:25 Today BofA Karuna Therapeutics price target raised to $261 from $160 at BofA 08/08/22 Stifel Cerevel Therapeutics price target raised to $54 from $50 at Stifel 08/08/22 Stifel Karuna Therapeutics price target raised to $260 from $185 at Stifel 08/08/22 JMP Securities Karuna Therapeutics price target raised to $315 from $190 at JMP Securities KRTX KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 Karuna Therapeutics reports Q2 EPS ($2.17), consensus ($2.09) 05/05/22 Karuna Therapeutics reports Q1 EPS ($1.95), consensus ($2.11) 02/24/22 Karuna Therapeutics reports Q4 EPS (94c), consensus ($1.73) 10 Aug 10 Nov ZLAB KRTX ZLAB Zai Lab $47.14 / +1.75 (+3.86%) 03/10/22 What You Missed On Wall Street On Thursday KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 07/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/15/22 2022 Biotech Summer Summit 08/10/22 Zai Lab - ZLAB
Earnings	Perrigo reports Q2 adjusted EPS 43c vs. 50c last year » 06:32 08/09/22 08/09 06:32 08/09/22 06:32 PRGO Perrigo $42.63 / -0.36 (-0.84%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events PRGO Perrigo $42.63 / -0.36 (-0.84%) 07/11/22 Perrigo subsidiary submits application to FDA for OTC birth control pill 06/14/22 Neptune Wellness appoints Raymond Silcock as CFO 06/01/22 Perrigo promotes Alison Ives to Chief Scientific Officer 05/26/22 Perrigo's omeprazole mini capsules for heartburn approved by FDA PRGO Perrigo $42.63 / -0.36 (-0.84%) 05/31/22 Jefferies Perrigo transferred with a Buy at Jefferies 11/11/21 Raymond James Perrigo price target lowered to $55 from $59 at Raymond James 10/14/21 Fly Intel: Top five analyst upgrades 10/14/21 Raymond James Raymond James upgrades Perrigo to buy on HRA deal, tax settlement PRGO Perrigo $42.63 / -0.36 (-0.84%) 05/11/22 Perrigo raises 2022 adjusted EPS view $2.30-$2.40 from $2.10-$2.30 05/11/22 Perrigo reports Q1 adjusted EPS 33c vs. 50c last year 03/01/22 Perrigo sees FY22 adjusted EPS $2.10-$2.30, consensus $2.67 03/01/22 Perrigo reports Q4 adjusted EPS 60c, consensus 56c PRGO Perrigo $42.63 / -0.36 (-0.84%) 05/13/22 Perrigo sees infant formula shortages through rest of 2022, Reuters says 08:30 Today Perrigo - PRGO
Earnings	Aramark raises FY22 organic revenue growth view to 31%-32% » 06:32 08/09/22 08/09 06:32 08/09/22 06:32 ARMK Aramark $35.27 / +0.16 (+0.46%) Prior view was 'at… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ARMK Aramark $35.27 / +0.16 (+0.46%) 06/07/22 Aramark, Starr announce plans for new restaurant at Wells Fargo Center 05/13/22 Soros buys Lucid, exits GM in Q1 05/10/22 Aramark plans to separate Aramark Uniform Services unit into public company 05/05/22 BrightView CFO John Feenan to retire, Brett Urban to succeed ARMK Aramark $35.27 / +0.16 (+0.46%) 03/29/22 Deutsche Bank Aramark initiated with a Hold at Deutsche Bank 03/11/22 BofA Aramark reinstated with a Buy at BofA 12/10/21 Stifel Aramark positioning for strategic transaction for Uniform business, says Stifel 12/09/21 Baird Aramark 'raises the growth bar' with analyst day targets, says Baird ARMK Aramark $35.27 / +0.16 (+0.46%) 06:30 Today Aramark reports Q3 adjusted EPS 25c, consensus 24c 05/10/22 Aramark sees FY22 organic growth 'at or very near' 27% 05/10/22 Aramark reports Q2 adjusted EPS 22c, consensus 22c 05/09/22 Notable companies reporting before tomorrow's open 08:30 Today Aramark - ARMK
Upgrade	BofA upgraded Federal Realty to Buy as COVID hindrances are removed » 06:32 08/09/22 08/09 06:32 08/09/22 06:32 FRT Federal Realty $107.13 / +1.29 (+1.22%) BofA analyst Craig… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings FRT Federal Realty $107.13 / +1.29 (+1.22%) 04/21/22 Federal Realty to acquire Kingstowne Towne Center in Virginia for $200M FRT Federal Realty $107.13 / +1.29 (+1.22%) 06:08 Today BofA Federal Realty upgraded to Buy from Neutral at BofA 08/04/22 Stifel Federal Realty price target lowered to $123 from $133 at Stifel 07/21/22 Mizuho Federal Realty price target lowered to $117 from $129 at Mizuho 07/15/22 Barclays Federal Realty price target lowered to $122 from $142 at Barclays FRT Federal Realty $107.13 / +1.29 (+1.22%) 08/04/22 Federal Realty raises FY2 FFO view to $6.10-$6.25 from $5.85-$6.05 08/04/22 Federal Realty reports Q2 FFO $1.65, consensus $1.50 05/05/22 Federal Realty raises FY22 FFO view to $5.85-$6.05 from $5.75-$5.95 05/05/22 Federal Realty reports Q1 FFO $1.50, consensus $1.44
Downgrade	Avalara downgraded to Hold from Buy at Berenberg » 06:31 08/09/22 08/09 06:31 08/09/22 06:31 AVLR Avalara $91.80 / -3.955 (-4.13%) Berenberg analyst Andrew… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly AVLR Avalara $91.80 / -3.955 (-4.13%) 08/08/22 Avalara to be acquired by Vista Equity Partners for $8.4B or $93.50 per share 05/05/22 Avalara names Ee Lyn Khoo as Chief People Officer AVLR Avalara $91.80 / -3.955 (-4.13%) 04:55 Today BMO Capital Avalara downgraded to Market Perform from Outperform at BMO Capital 08/08/22 Mizuho Avalara downgraded to Neutral from Buy at Mizuho 08/08/22 Evercore ISI Avalara downgraded to In Line from Outperform at Evercore ISI 08/08/22 Canaccord Avalara downgraded to Hold from Buy at Canaccord AVLR Avalara $91.80 / -3.955 (-4.13%) 08/08/22 Avalara reports Q2 EPS (2c), consensus (7) 06/28/22 Avalara targets fiscal 2025 organic revenue growth 20%-25% 05/05/22 Avalara sees FY22 revenue $867M-$871M, consensus $856.96M 05/05/22 Avalara sees Q2 revenue $208M-$210M, consensus $205.65M AVLR Avalara $91.80 / -3.955 (-4.13%) 07/07/22 Avalara approached about possible takeover, blog report says AVLR Avalara $91.80 / -3.955 (-4.13%) 08/08/22 Fly Intel: Pre-market Movers
Earnings	Aramark reports Q3 adjusted EPS 25c, consensus 24c » 06:30 08/09/22 08/09 06:30 08/09/22 06:30 ARMK Aramark $35.27 / +0.16 (+0.46%) Reports Q3 revenue $4.1B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ARMK Aramark $35.27 / +0.16 (+0.46%) 06/07/22 Aramark, Starr announce plans for new restaurant at Wells Fargo Center 05/13/22 Soros buys Lucid, exits GM in Q1 05/10/22 Aramark plans to separate Aramark Uniform Services unit into public company 05/05/22 BrightView CFO John Feenan to retire, Brett Urban to succeed ARMK Aramark $35.27 / +0.16 (+0.46%) 03/29/22 Deutsche Bank Aramark initiated with a Hold at Deutsche Bank 03/11/22 BofA Aramark reinstated with a Buy at BofA 12/10/21 Stifel Aramark positioning for strategic transaction for Uniform business, says Stifel 12/09/21 Baird Aramark 'raises the growth bar' with analyst day targets, says Baird ARMK Aramark $35.27 / +0.16 (+0.46%) 05/10/22 Aramark sees FY22 organic growth 'at or very near' 27% 05/10/22 Aramark reports Q2 adjusted EPS 22c, consensus 22c 05/09/22 Notable companies reporting before tomorrow's open 05/09/22 Notable companies reporting before tomorrow's open 08:30 Today Aramark - ARMK
Periodicals	US solar industry facing disruptions with new import ban, WSJ reports » 06:29 08/09/22 08/09 06:29 08/09/22 06:29 CSIQ Canadian Solar $39.13 / +0.44 (+1.14%) , SPWR SunPower $24.05 / -0.015 (-0.06%) , FSLR First Solar $106.66 / +4.78 (+4.69%) , TSL Trina Solar / + , JASO JA Solar $7.50 / + (+0.00%) , YGE Yingli Green Energy / + The U.S. solar industry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options CSIQ SPWR FSLR CSIQ Canadian Solar $39.13 / +0.44 (+1.14%) 07/25/22 Canadian Solar, Gresham House complete renewables sale 07/07/22 Canadian Solar completes sale of two solar farms to CalEnergy Resources 06/16/22 Canadian Solar acquires 400 MWh of storage projects under development 06/15/22 Canadian Solar secures $28M in financing for Lavras II project in Brazil SPWR SunPower $24.05 / -0.015 (-0.06%) 06/06/22 President Biden announces executive action on clean energy technologies 05/25/22 Clearway Energy announces GIP forms renewables partnership with TotalEnergies 05/12/22 SunPower partners with Ikea U.S. for home solar solutions 05/05/22 SunPower backs 2022 adjusted EBITDA view of $90M-$110M FSLR First Solar $106.66 / +4.78 (+4.69%) 07/28/22 First Solar to supply 2.4 GW of PV solar modules to Intersect Power 07/26/22 First Solar issues 2022 Sustainability Report 07/25/22 First Solar announces Akuo placed order for 500MW of thin film PV solar modules 07/21/22 First Solar to supply Solarvest Holdings with 93 MW for Malaysian projects CSIQ SPWR FSLR TSL JASO YGE CSIQ Canadian Solar $39.13 / +0.44 (+1.14%) 08/08/22 JPMorgan Canadian Solar price target raised to $42 from $38 at JPMorgan 07/20/22 JPMorgan Canadian Solar price target raised to $38 from $36 at JPMorgan 06/29/22 Roth Capital Roth sees CBP requiring quartzite docs as 'major problem' for solar industry 03/28/22 Citi Canadian Solar price target raised to $45 from $40 at Citi SPWR SunPower $24.05 / -0.015 (-0.06%) 08/08/22 JPMorgan SunPower price target raised to $25 from $20 at JPMorgan 08/04/22 Barclays SunPower initiated with an Equal Weight at Barclays 07/22/22 Roth Capital SunPower price target lowered to $18 from $20 at Roth Capital 07/20/22 JPMorgan SunPower price target raised to $20 from $19 at JPMorgan FSLR First Solar $106.66 / +4.78 (+4.69%) 08/08/22 JPMorgan First Solar upgraded to Overweight from Neutral at JPMorgan 08/08/22 Guggenheim First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act 08/08/22 Guggenheim First Solar upgraded to Buy from Neutral at Guggenheim 08/05/22 Argus First Solar price target raised to $123 from $104 at Argus TSL Trina Solar / + JASO JA Solar $7.50 / + (+0.00%) YGE Yingli Green Energy / + CSIQ SPWR FSLR CSIQ Canadian Solar $39.13 / +0.44 (+1.14%) 05/24/22 Canadian Solar reports Q1 EPS 14c, consensus (13c) 03/17/22 Canadian Solar reports Q4 EPS 17c, consensus 33c SPWR SunPower $24.05 / -0.015 (-0.06%) 08/02/22 SunPower sees FY22 adjusted EBITDA $90M-$110M 08/02/22 SunPower reports Q2 non-GAAP EPS 3c, consensus 4c 08/01/22 Notable companies reporting before tomorrow's open 08/01/22 Notable companies reporting before tomorrow's open FSLR First Solar $106.66 / +4.78 (+4.69%) 07/28/22 First Solar lowers FY22 EPS guidance to (25c)-25c from 0c-60c, consensus (4c) 07/28/22 First Solar reports Q2 EPS 52c, consensus 23c 07/28/22 Notable companies reporting after market close 04/28/22 First Solar backs FY22 revenue view $2.4B-$2.6B, consensus $2.54B CSIQ SPWR FSLR TSL JASO YGE CSIQ Canadian Solar $39.13 / +0.44 (+1.14%) 07/15/22 Machin will not support new spending on climate measures, Bloomberg reports 06/27/22 German ministry says EU states agree to 40% renewables target, Reuters reports 06/06/22 White House to waive some solar panel tariffs for 24 months, Reuters reports 03/28/22 Commerce Department to investigate Asian solar-panel makers, Bloomberg says SPWR SunPower $24.05 / -0.015 (-0.06%) 07/15/22 Machin will not support new spending on climate measures, Bloomberg reports 06/27/22 German ministry says EU states agree to 40% renewables target, Reuters reports 06/06/22 White House to waive some solar panel tariffs for 24 months, Reuters reports 03/31/22 SunPower says in late-stage talks with First Solar for residential panels FSLR First Solar $106.66 / +4.78 (+4.69%) 07/15/22 Machin will not support new spending on climate measures, Bloomberg reports 06/27/22 German ministry says EU states agree to 40% renewables target, Reuters reports 06/06/22 White House to waive some solar panel tariffs for 24 months, Reuters reports 03/31/22 SunPower says in late-stage talks with First Solar for residential panels TSL Trina Solar / + 07/15/22 Machin will not support new spending on climate measures, Bloomberg reports JASO JA Solar $7.50 / + (+0.00%) 07/15/22 Machin will not support new spending on climate measures, Bloomberg reports YGE Yingli Green Energy / + 07/15/22 Machin will not support new spending on climate measures, Bloomberg reports CSIQ SPWR FSLR CSIQ Canadian Solar $39.13 / +0.44 (+1.14%) 07/05/22 What You Missed This Week in EVs and Clean Energy 06/29/22 Solar stocks slide as analyst says products detained under new law 06/27/22 What You Missed This Week in EVs and Clean Energy 06/06/22 What You Missed On Wall Street On Monday SPWR SunPower $24.05 / -0.015 (-0.06%) 08/08/22 What You Missed This Week in EVs and Clean Energy 08/02/22 Fly Intel: Pre-market Movers 07/05/22 What You Missed This Week in EVs and Clean Energy 06/29/22 Solar stocks slide as analyst says products detained under new law FSLR First Solar $106.66 / +4.78 (+4.69%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 Fly Insider: Community Health, Calix among week's notable insider trades 08/08/22 What You Missed On Wall Street This Morning 08/08/22 What You Missed This Week in EVs and Clean Energy 08/12/22 Annual Industrials, Energy & Airlines Conference 08/18/22 Canadian Solar - CSIQ SPWR FSLR SPWR SunPower $24.05 / -0.015 (-0.06%) 07/28/22 SunPower call volume above normal and directionally bullish 07/18/22 Unusually active option classes on open July 18th 06/21/22 SunPower call volume above normal and directionally bullish 04/26/22 SunPower call volume above normal and directionally bullish FSLR First Solar $106.66 / +4.78 (+4.69%) 08/08/22 Unusually active option classes on open August 8th 08/05/22 Unusually active option classes on open August 5th 07/28/22 First Solar options imply 6.2% move in share price post-earnings 07/28/22 Unusually active option classes on open July 28th
Downgrade	Baird downgrades Bed Bath & Beyond to sell after 86% two-day rally » 06:29 08/09/22 08/09 06:29 08/09/22 06:29 BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) Baird analyst Justin… Baird analyst Justin Kleber downgraded Bed Bath & Beyond to Underperform from Neutral with an unchanged price target of $4. The stock closed Monday up 40% to $11.41. The shares have surged 148% since July 27, including 86% in the past two trading days, Kleber tells investors in a research note. The analyst says the rally has been "driven by non-fundamentally focused market participants." With market share losses accelerating and Bed Bath "burning cash," the stock's fundamental risk/reward looks unattractive, contends Kleber. He estimates the company would need to generate over $350M of EBITDA by fiscal 2025 to justify the stock's current $2.3B enterprise value. This is a "tall order given the current macro/sector backdrop," the analyst writes. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) 08/03/22 Bed Bath & Beyond down 3% to $5.62 after Bloomberg report on credit talks 07/21/22 Freeman Capital discloses 6.21% stake in Bed Bath & Beyond 07/07/22 Bed Bath & Beyond interim CEO Sue Gove buys 50,000 shares of common stock 07/04/22 Fly Intel: Top five weekend stock stories BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) 05:56 Today Baird Bed Bath & Beyond downgraded to Underperform from Neutral at Baird 08/08/22 Odeon Capital Bed Bath & Beyond cut to Hold at Odeon Capital following doubling in a week 08/08/22 Odeon Capital Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital 06/30/22 B. Riley Bed Bath & Beyond price target lowered to $5 from $7 at B. Riley BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) 06/29/22 Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39) 06/28/22 Notable companies reporting before tomorrow's open 06/28/22 Notable companies reporting before tomorrow's open 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) 08/03/22 Bed Bath & Beyond weighing private loans, Bloomberg reports 08/03/22 Bed Bath & Beyond in talks with private credit providers, Bloomberg says 07/02/22 Bed Bath & Beyond remodeling not working, Barron's says 06/29/22 Ryan Cohen happy with Bed Bath & Beyond CEO exit, CNBC reports BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight 08/03/22 What You Missed On Wall Street On Wednesday 07/23/22 Short Report: Revlon shorts recede, stock retreats as buyout news fades 07/09/22 Short Report: Carvana, Bed Bath Beyond short interest continues to grow BBBY Bed Bath & Beyond $11.41 / +3.26 (+40.00%) 08/08/22 Unusually active option classes on open August 8th 08/05/22 Bed Bath & Beyond call volume above normal and directionally bullish 08/05/22 Unusually active option classes on open August 5th 08/04/22 Bed Bath & Beyond call volume above normal and directionally bullish
Periodicals	Carlyle's CEO contract proposal was met with silence from board, WSJ reports » 06:29 08/09/22 08/09 06:29 08/09/22 06:29 CG Carlyle Group $35.30 / -2.34 (-6.22%) As Carlyle CEO Kewsong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options CG Carlyle Group $35.30 / -2.34 (-6.22%) 08/08/22 Carlyle Group CEO Kewsong Lee to step down, Bill Conway to be interim CEO 07/12/22 Madison Dearborn Partners to acquire majority stake in Unison from Carlyle 05/16/22 Carlyle to acquire ManTech for $96 per share in $4.2B enterprise value deal 05/09/22 White Mountains to sell NSM Insurance Group to Carlyle Group CG Carlyle Group $35.30 / -2.34 (-6.22%) 07/29/22 Evercore ISI Carlyle Group upgraded to Outperform from In Line at Evercore ISI 07/13/22 Deutsche Bank Carlyle Group price target lowered to $56 from $64 at Deutsche Bank 06/08/22 JMP Securities Carlyle Group initiated with an Outperform at JMP Securities 05/19/22 Deutsche Bank Carlyle Group price target lowered to $64 from $68 at Deutsche Bank CG Carlyle Group $35.30 / -2.34 (-6.22%) 04/29/22 Carlyle Group reports Q1 EPS 74c vs. 58c last year 10 Nov CG Carlyle Group $35.30 / -2.34 (-6.22%) 07/19/22 Carlyle exploring sale of remainder of Sequa, Bloomberg says 07/19/22 Carlyle exploring sale of remainder of Sequa, Bloomberg says 07/12/22 Carlyle Group, Permira may bid over $1B for Reorg, Bloomberg says 05/16/22 Carlyle in advanced discussions to acquire ManTech, Bloomberg reports CG Carlyle Group $35.30 / -2.34 (-6.22%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 07/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/19/22 What You Missed On Wall Street On Tuesday CG Carlyle Group $35.30 / -2.34 (-6.22%) 02/22/22 Carlyle Group put volume heavy and directionally bearish

Recommendations	XPO Logistics price target raised to $80 from $70 at Raymond James » 06:26 08/09/22 08/09 06:26 08/09/22 06:26 XPO XPO Logistics $57.86 / -2.02 (-3.37%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options XPO XPO Logistics $57.86 / -2.02 (-3.37%) 08/04/22 XPO Logistics says Mario Harik to succeed Brad Jacobs as CEO 07/19/22 XPO named official transport partner for Tour de France Femmes avec Zwift 07/12/22 XPO Logistics announces RXO as company name for planned spin-off 06/29/22 XPO Logistics expands use of sustainable biofuel at Tour de France XPO XPO Logistics $57.86 / -2.02 (-3.37%) 08/08/22 Citi XPO Logistics price target raised to $75 from $70 at Citi 07/15/22 Raymond James XPO Logistics price target lowered to $70 from $90 at Raymond James 07/12/22 Evercore ISI XPO Logistics price target lowered to $67 from $83 at Evercore ISI 07/12/22 JPMorgan XPO Logistics price target lowered to $72 from $81 at JPMorgan XPO XPO Logistics $57.86 / -2.02 (-3.37%) 08/04/22 XPO Logistics raises FY22 adjusted EPS view to $5.55-$5.90 from $5.20-$5.60 08/04/22 XPO Logistics reports Q2 adjusted EPS $1.81, consensus $1.50 05/09/22 XPO Logistics sees FY22 EPS $5.20-$5.60, consensus $5.19 05/09/22 XPO Logistics reports Q1 EPS $1.25, consensus 93c XPO XPO Logistics $57.86 / -2.02 (-3.37%) 07/08/22 What You Missed On Wall Street On Friday 07/08/22 What You Missed On Wall Street This Morning 07/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/09/22 What You Missed On Wall Street On Wednesday 08/12/22 Annual Industrials, Energy & Airlines Conference XPO XPO Logistics $57.86 / -2.02 (-3.37%) 08/08/22 XPO Logistics put volume heavy and directionally bearish 04/14/22 Unusually active option classes on open April 14th
Recommendations	Karuna Therapeutics price target raised to $261 from $160 at BofA » 06:25 08/09/22 08/09 06:25 08/09/22 06:25 KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) BofA analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial 08/08/22 Karuna Therapeutics says Phase 3 EMERGENT-2 trial met primary endpoint KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 Stifel Cerevel Therapeutics price target raised to $54 from $50 at Stifel 08/08/22 Stifel Karuna Therapeutics price target raised to $260 from $185 at Stifel 08/08/22 JMP Securities Karuna Therapeutics price target raised to $315 from $190 at JMP Securities 08/08/22 Citi Karuna Therapeutics price target raised to $280 from $162 at Citi KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 Karuna Therapeutics reports Q2 EPS ($2.17), consensus ($2.09) 05/05/22 Karuna Therapeutics reports Q1 EPS ($1.95), consensus ($2.11) 02/24/22 Karuna Therapeutics reports Q4 EPS (94c), consensus ($1.73) 10 Aug 10 Nov KRTX Karuna Therapeutics $241.52 / +101.41 (+72.38%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 07/14/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/15/22 2022 Biotech Summer Summit
Recommendations	Aurinia Pharmaceuticals price target lowered to $26 from $30 at H.C. Wainwright » 06:24 08/09/22 08/09 06:24 08/09/22 06:24 AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) 07/26/22 Aurinia says USPTO to institute trial on Inter Partes review of Lupkynis patent 07/22/22 Aurinia Pharmaceuticals announces positive CHMP opinion for LUPKYNIS 07/14/22 Aurinia Pharmaceuticals names Scott Habig chief commercial officer 06/03/22 Aurinia Pharmaceuticals presents data from Lupkynis trial AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) 05/05/22 Cantor Fitzgerald Aurinia Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald 05/04/22 H.C. Wainwright Aurinia Pharmaceuticals price target lowered to $30 from $33 at H.C. Wainwright 04/28/22 RBC Capital Aurinia Pharmaceuticals price target lowered to $22 from $27 at RBC Capital 03/01/22 RBC Capital Aurinia Pharmaceuticals price target lowered to $27 from $31 at RBC Capital AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) 08/04/22 Aurinia Pharmaceuticals reports Q2 EPS (25c), consensus (22c) 05/10/22 Aurinia Pharmaceuticals reports Q1 EPS (27c), consensus (27c) 02/28/22 Aurinia Pharmaceuticals sees 2022 net revenue $115M-$135M 02/28/22 Aurinia Pharmaceuticals reports Q4 EPS (25c) vs. (6c) last year AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) 07/01/22 Aurinia Pharmaceuticals M&A rumor discussed by Betaville AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/22 What You Missed On Wall Street On Monday AUPH Aurinia Pharmaceuticals $8.28 / -0.075 (-0.90%) 07/27/22 Aurinia Pharmaceuticals call volume above normal and directionally bullish 07/01/22 Aurinia Pharmaceuticals call volume above normal and directionally bullish 06/22/22 Aurinia Pharmaceuticals call volume above normal and directionally bullish 06/08/22 Aurinia Pharmaceuticals call volume above normal and directionally bullish
Recommendations	Pliant Therapeutics price target raised to $53 from $45 at H.C. Wainwright » 06:24 08/09/22 08/09 06:24 08/09/22 06:24 PLRX Pliant Therapeutics $18.95 / +0.04 (+0.21%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PLRX Pliant Therapeutics $18.95 / +0.04 (+0.21%) 07/21/22 Pliant receives FDA Fast Track designation for PLN-74809 for treating PSC 07/11/22 Pliant Therapeutics trading resumes 07/11/22 Pliant Therapeutics trading halted, volatility trading pause 07/10/22 Pliant announces safety, efficacy data from Phase 2a INTEGRIS-IPF trial PLRX Pliant Therapeutics $18.95 / +0.04 (+0.21%) 07/26/22 Cantor Fitzgerald Pliant Therapeutics price target raised to $40 from $36 at Cantor Fitzgerald 07/20/22 SVB Securities Pliant Therapeutics initiated with an Outperform at SVB Securities 07/11/22 Piper Sandler Pliant Therapeutics price target raised to $40 from $27 at Piper Sandler 07/11/22 Cantor Fitzgerald Pliant Therapeutics price target raised to $36 from $28 at Cantor Fitzgerald PLRX Pliant Therapeutics $18.95 / +0.04 (+0.21%) 08/08/22 Pliant Therapeutics reports Q2 EPS (82c), consensus (81c) 05/09/22 Pliant Therapeutics reports Q1 EPS (78c), consensus (75c) 02/28/22 Pliant Therapeutics reports Q4 EPS (68c), consensus (76c) 13 Jul PLRX Pliant Therapeutics $18.95 / +0.04 (+0.21%) 07/11/22 What You Missed On Wall Street On Monday 07/11/22 What You Missed On Wall Street This Morning PLRX Pliant Therapeutics $18.95 / +0.04 (+0.21%) 07/12/22 Unusually active option classes on open July 12th
Syndicate	PennantPark Floating Rate 4M share Spot Secondary priced at $12.40 » 06:23 08/09/22 08/09 06:23 08/09/22 06:23 PFLT PennantPark Floating Rate $13.21 / +0.3 (+2.32%) The deal range was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate PFLT PennantPark Floating Rate $13.21 / +0.3 (+2.32%) 05/06/22 PennantPark Floating Rate appoints Jose Briones to board of directors 03/14/22 PennantPark Floating Rate increases commitment to joint venture PFLT PennantPark Floating Rate $13.21 / +0.3 (+2.32%) 08/09/21 Ladenburg PennantPark Floating Rate downgraded to Neutral at Ladenburg 08/09/21 Ladenburg PennantPark Floating Rate downgraded to Neutral from Buy at Ladenburg PFLT PennantPark Floating Rate $13.21 / +0.3 (+2.32%) 05/04/22 PennantPark Floating Rate reports Q2 EPS 29c, consensus 28c 09 Aug
Recommendations	Acadia Pharmaceuticals price target raised to $25 from $20 at H.C. Wainwright » 06:23 08/09/22 08/09 06:23 08/09/22 06:23 ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 08/05/22 Acadia Pharmaceuticals receives CRL from FDA regarding Nuplazid sNDA 07/18/22 Acadia Pharmaceuticals submits NDA to FDA for Rett Syndrome treatment 06/21/22 Acadia Pharmaceuticals down 30% after FDA AdCom vote against Nuplazid 06/18/22 Acadia 'disappointed' with PDAC vote of 9 to 3 against Nuplazid in ADP ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 05:40 Today Citi Acadia Pharmaceuticals price target raised to $17 from $15 at Citi 08/08/22 Cowen Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen 08/05/22 Citi Acadia Pharmaceuticals downgraded to Neutral from Buy at Citi 06/22/22 Canaccord Acadia Pharmaceuticals price target lowered to $20 from $31 at Canaccord ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 08/08/22 Acadia Pharmaceuticals narrows FY22 revenue view to $510M-$540M from $510M-$560M 08/08/22 Acadia Pharmaceuticals reports Q2 EPS (21c), consensus (25c) 05/04/22 Acadia Pharmaceuticals backs FY22 revenue view of $510M-$560M, consensus $540.7M 05/04/22 Acadia Pharmaceuticals reports Q1 EPS (70c), consensus (60c) ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 06/16/22 What You Missed On Wall Street On Thursday ACAD Acadia Pharmaceuticals $16.65 / +0.225 (+1.37%) 07/15/22 Acadia call volume above normal and directionally bullish 07/12/22 Acadia call volume above normal and directionally bullish 06/15/22 Unusually active option classes on open June 15th 05/04/22 Acadia options imply 19.6% move in share price post-earnings
Recommendations	PubMatic price target lowered to $34 from $40 at JMP Securities » 06:23 08/09/22 08/09 06:23 08/09/22 06:23 PUBM PubMatic $17.81 / +0.365 (+2.09%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PUBM PubMatic $17.81 / +0.365 (+2.09%) 06/21/22 PubMatic to join broad-market Russell 3000 and the small-cap 2000 indexes 06/16/22 PubMatic achieves 100% renewable energy across global data centers 06/07/22 PubMatic names Zendesk CFO Glaser and JFrog CFO Shulman to board 02/24/22 PubMatic selected by GroupM to support supply chain PUBM PubMatic $17.81 / +0.365 (+2.09%) 08/04/22 Jefferies PubMatic price target lowered to $20 from $23 at Jefferies 08/01/22 KeyBanc PubMatic downgraded to Sector Weight from Overweight at KeyBanc 07/27/22 KeyBanc Google's cookie phase-out delay not surprising, says KeyBanc 07/27/22 RBC Capital Google cookie phase-out delay adds another year of uncertainty, says RBC Capital PUBM PubMatic $17.81 / +0.365 (+2.09%) 08/08/22 PubMatic cuts FY22 revenue view to $277M-$281M from $282M-$286M 08/08/22 PubMatic sees Q3 revenue $66M-$68M, consensus $69.51M 08/08/22 PubMatic reports Q2 EPS 23c vs. 18c last year 05/09/22 PubMatic backs FY22 revenue view $282M-$286M, consensus $284.22M PUBM PubMatic $17.81 / +0.365 (+2.09%) 06/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/28/22 Fly Intel: After-Hours Movers 08/16/22 PubMatic PUBM PubMatic $17.81 / +0.365 (+2.09%) 02/25/22 Largest borrow rate increases among liquid names
Hot Stocks	Village Farms announces Leli Holland been granted tenth cannabis license » 06:23 08/09/22 08/09 06:23 08/09/22 06:23 VFF Village Farms $3.13 / -0.06 (-1.88%) Village Farms announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events VFF Village Farms $3.13 / -0.06 (-1.88%) 07/19/22 Pure Sunfarms launches The Original Fraser Valley Weed Co. 05/03/22 Village Farms' Pure Sunfarms, NOYA bring Cookies sun-grown flower to Ontario 04/20/22 Pure Sunfarms launches Pure Sunfarms FLOWERHOOD 03/09/22 Village Farms' Pure Sunfarms receives EU GMP certification for production unit VFF Village Farms $3.13 / -0.06 (-1.88%) 05/11/22 Craig-Hallum Village Farms price target lowered to $5 from $15 at Craig-Hallum 05/11/22 Raymond James Village Farms downgraded to Outperform from Strong Buy at Raymond James 05/10/22 Alliance Global Partners Village Farms price target lowered to $10 from $17 at Alliance Global Partners 03/03/22 Stifel Village Farms downgraded to Hold from Buy at Stifel VFF Village Farms $3.13 / -0.06 (-1.88%) 06:21 Today Village Farms reports Q2 EPS (41c) vs. (13c) last year 05/10/22 Village Farms reports Q1 EPS (7c), consensus (1c) 03/01/22 Village Farms reports Q4 EPS 3c, consensus 2c 08:30 Today Village Farms - VFF
Recommendations	uniQure selloff brings attractive entry point, says H.C. Wainwright » 06:21 08/09/22 08/09 06:21 08/09/22 06:21 QURE uniQure $18.60 / -6.92 (-27.12%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events QURE uniQure $18.60 / -6.92 (-27.12%) 06/23/22 uniQure provides update on low-dose cohort in Phase I/II trial of AMT-130 06/22/22 uniQure announces grant equity awards to 32 new employees 05/24/22 uniQure announces FDA accepts priority review BLA for etranacogene dezaparvovec 05/11/22 uniQure announces inducement grants under Nasdaq listing rule 5635(c)(4) QURE uniQure $18.60 / -6.92 (-27.12%) 08/08/22 Chardan uniQure price target lowered to $60 from $65 at Chardan 08/08/22 Truist uniQure's high-dose HD data still on track for 1H23, says Truist 05/05/22 Stifel uniQure price target lowered to $37 from $66 at Stifel 04/13/22 Truist uniQure price target lowered to $51 from $90 at Truist QURE uniQure $18.60 / -6.92 (-27.12%) 08/08/22 uniQure reports Q2 EPS (84c) vs $8.51 last year 05/02/22 uniQure reports Q1 EPS ($1.00), consensus (93c) 02/25/22 uniQure reports 2021 EPS $7.04, consensus $6.20 QURE uniQure $18.60 / -6.92 (-27.12%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 06/23/22 What You Missed On Wall Street On Thursday 06/23/22 What You Missed On Wall Street This Morning 10/03/22 6th Annual Genetic Medicines Conference
Earnings	Village Farms reports Q2 EPS (41c) vs. (13c) last year » 06:21 08/09/22 08/09 06:21 08/09/22 06:21 VFF Village Farms $3.13 / -0.06 (-1.88%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events VFF Village Farms $3.13 / -0.06 (-1.88%) 07/19/22 Pure Sunfarms launches The Original Fraser Valley Weed Co. 05/03/22 Village Farms' Pure Sunfarms, NOYA bring Cookies sun-grown flower to Ontario 04/20/22 Pure Sunfarms launches Pure Sunfarms FLOWERHOOD 03/09/22 Village Farms' Pure Sunfarms receives EU GMP certification for production unit VFF Village Farms $3.13 / -0.06 (-1.88%) 05/11/22 Craig-Hallum Village Farms price target lowered to $5 from $15 at Craig-Hallum 05/11/22 Raymond James Village Farms downgraded to Outperform from Strong Buy at Raymond James 05/10/22 Alliance Global Partners Village Farms price target lowered to $10 from $17 at Alliance Global Partners 03/03/22 Stifel Village Farms downgraded to Hold from Buy at Stifel VFF Village Farms $3.13 / -0.06 (-1.88%) 05/10/22 Village Farms reports Q1 EPS (7c), consensus (1c) 03/01/22 Village Farms reports Q4 EPS 3c, consensus 2c 08:30 Today Village Farms - VFF

General news	European stock markets are narrowly mixed, » 06:20 08/09/22 08/09 06:20 08/09/22 06:20 $ECON Economic Data / + European stock markets… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
General news	U.S. productivity preview » 06:20 08/09/22 08/09 06:20 08/09/22 06:20 $ECON Economic Data / + U.S. productivity… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Upgrade	Myovant Sciences upgraded to Outperform from Market Perform at SVB Securities » 06:19 08/09/22 08/09 06:19 08/09/22 06:19 MYOV Myovant Sciences / + SVB Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly MYOV Myovant Sciences / + 08/07/22 Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE 06/17/22 Pfizer, Myovant Sciences announce results of Phase 3 SPIRIT 1, SPIRIT 2 studies 06/07/22 Better Therapeutics appoints Karbe as Chief Executive Officer 06/02/22 Pfizer, Myovant Sciences announce FDA approval of sNDA for MYFEMBREE MYOV Myovant Sciences / + 06:11 Today SVB Securities Myovant Sciences upgraded to Outperform from Market Perform at SVB Securities 04/13/22 Baird Myovant Sciences price target lowered to $20 from $30 at Baird 09/09/21 SVB Leerink SVB Leerink starts Myovant at Market Perform 09/09/21 SVB Leerink Myovant Sciences initiated with a Market Perform at SVB Leerink MYOV Myovant Sciences / + 05/10/22 Myovant Sciences reports Q4 EPS (63c), consensus (57c) MYOV Myovant Sciences / + 04/12/22 What You Missed On Wall Street On Tuesday 04/12/22 What You Missed On Wall Street This Morning 04/12/22 Fly Intel: Pre-market Movers
Recommendations	Precigen price target lowered to $6 from $10 at H.C. Wainwright » 06:19 08/09/22 08/09 06:19 08/09/22 06:19 PGEN Precigen $2.07 / -0.01 (-0.48%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PGEN Precigen $2.07 / -0.01 (-0.48%) 08/08/22 Precigen expectsTrans Ova Genetics sale to close in Q3 07/05/22 Precigen enters agreement to divest non-healthcare subsidiary Trans Ova to URUS 04/04/22 Precigen says FDA grants Fast Track designation for PRGN-3006 UltraCAR-T PGEN Precigen $2.07 / -0.01 (-0.48%) 07/05/22 Stifel Precigen subsidiary sale relieves convertible debt overhang, says Stifel PGEN Precigen $2.07 / -0.01 (-0.48%) 08/08/22 Precigen reports Q2 EPS (13c), consensus (16c) 05/09/22 Precigen reports Q1 EPS (10c), consensus (13c) 03/01/22 Precigen reports Q4 EPS (13c), consensus (14c)
Recommendations	SpringsWorks Therapeutics price target lowered to $94 from $95 at H.C. Wainwright » 06:18 08/09/22 08/09 06:18 08/09/22 06:18 SWTX SpringsWorks Therapeutics $39.68 / +2.825 (+7.67%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SWTX SpringsWorks Therapeutics $39.68 / +2.825 (+7.67%) 05/26/22 SpringsWorks Therapeutics presents Nirogacestat Clinical Data at 2022 ASCO 05/24/22 SpringsWorks Therapeutics: Nirogacestat achieved endpoints in Phase 3 DeFi trial 04/19/22 SpringsWorks announces agreeement with Regeneron for nirogacestat SWTX SpringsWorks Therapeutics $39.68 / +2.825 (+7.67%) 06/06/22 H.C. Wainwright SpringsWorks price target lowered to $95 from $142 at H.C. Wainwright 06/06/22 H.C. Wainwright Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright 05/27/22 Wedbush SpringsWorks Therapeutics price target lowered to $50 from $110 at Wedbush 05/24/22 Goldman Sachs SpringsWorks Therapeutics price target raised to $82 from $76 at Goldman Sachs SWTX SpringsWorks Therapeutics $39.68 / +2.825 (+7.67%) 08/04/22 SpringsWorks Therapeutics reports Q2 EPS ($1.41), consensus ($1.20) 05/05/22 SpringsWorks Therapeutics reports Q1 EPS ($1.26), consensus ($1.02) 02/24/22 SpringsWorks Therapeutics reports Q4 EPS ($1.15), consensus (88c) SWTX SpringsWorks Therapeutics $39.68 / +2.825 (+7.67%) 06/24/22 Sell these stocks now, proven algorithm says 06/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/26/22 Fly Intel: After-Hours Movers 05/24/22 What You Missed On Wall Street On Tuesday 09/10/22 ESMO Congress 2022

Events

Earnings calls, analyst events, roadshows and more

XYF
Today at 07:00

X Financial - XYF Conference Calls
CBT
Today at 08:00

Cabot - CBT Conference Calls
CIFR
Today at 08:00

Cipher Mining - CIFR Conference Calls
PLNT
Today at 08:00

Planet Fitness - PLNT Conference Calls
ECOM
Today at 08:00

ChannelAdvisor - ECOM Conference Calls
MRMD
Today at 08:00

Marimed - MRMD Conference Calls
FWRG
Today at 08:00

First Watch Restaurant - FWRG Conference Calls
NE
Today at 08:00

Noble Corp. - NE Conference Calls
ESAB
Today at 08:00

ESAB - ESAB Conference Calls
BHC
Today at 08:00

Bausch Health - BHC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Fisker announces Fisker Finance platform

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access